When was Cognoptix founded?

Cognoptix was founded in 2001 and raised its 1st funding round 5 years after it was founded.

Where is Cognoptix located?

Cognoptix is headquartered in Acton, United States.

How many employees does Cognoptix have?

As of May 31, 2026, the latest employee count at Cognoptix is 1.

Is Cognoptix a funded company?

Cognoptix is a funded company, having raised a total of $41.3M across 8 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jan 23, 2006.

When was the latest funding round of Cognoptix?

Cognoptix's latest funding was a $***** Series D round on Sep 28, 2020, with participation from 3 investors.

Where does Cognoptix rank among its competitors?

Cognoptix ranks 19th amongst 137 active competitors, of which 38 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was neuroClues, which secured $11.6M in Apr, 2026.

Who are the top competitors of Cognoptix?

Cognoptix's top competitors include Neuralight, neuroClues and Tobii Dynavox. Among them, neuroClues secured the most recent funding round in April, 2026.

Cognoptix - 2026 Company Profile, Team, Funding & Competitors

Company Details

Cognoptix is a developer of non-invasive eye scanning tests for early detection of Alzheimer's Disease. The company is developing technologies to enable non-invasive quantitative measurements of amyloid aggregates in the eye, to examine and measure deposits in specific areas of the lens as a means of early detection of Alzheimer’s disease. Their SAPPHIRE eye test uses Fluorescent Ligand Scanning (FLS) is a technique in which a compound composed of beta amyloid-specific small molecules is dropped into a patient’s eye, which is scanned by the SAPPHIRE instrument.

Key Metrics

Founded Year

2001

Location

Acton, United States

Stage

Series D

Total Funding

$41.3M in 8 rounds

Latest Funding Round

Series D, Sep 28, 2020, $*****

Investors

Launchpad Venture Group & 13 more

Ranked

19^th among 137 active competitors

Employee Count

1 as on May 31, 2026

Similar Companies

Neuralight & 145 more

View Cognoptix's full profile

Cognoptix is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Cognoptix, Inc. CIN: 43580545 , Belgium, Active	Oct 10, 2001	-	2 (As on Dec 31, 2021)	-
NEUROPTIX CORP CIN: 1347741 , United States, Active		$1 - $1M (As on Jan 05, 2011)	-	-

Cognoptix has raised a total funding of $41.3M over 8 rounds. Its first funding round was on Jan 23, 2006. Its latest funding round was a Series D round on Sep 28, 2020 for $*****. 3 investors participated in its latest round. Cognoptix has 14 institutional investors.

Here is the list of recent funding rounds of Cognoptix:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 28, 2020	3143244	Series D	6848099	9237191	5160348	9705782
Sep 19, 2014	7660966	Series D	3101353	1912065	9727355	Inventages & 1 more
Apr 24, 2014	8628935	Conventional Debt	2479351	3433767	1698438	8727297

Access funding benchmarks and valuations. Sign up today!

View details of Cognoptix's funding rounds and investors

The founders of Cognoptix are Leo Chylack and Lee Goldstein.

Here are the details of Cognoptix's key team members:

Leo Chylack: Co-Founder of Cognoptix.
Contact Info: 1 email address
Lee Goldstein: Co-Founder of Cognoptix.
Contact Info: 1 email address

Cognoptix's Board of Directors

Cognoptix's board has 8 active members. Richard Gill, Gunnar Weikert, Gerald D. Cagle, Werner Schaefer, Tom Trometer, Christine de los Reyes, Paul Hartung and Rainer Hoegg are independent board members.

Here is the list of Cognoptix's board of directors:

Name	Type	Representing	Status	Duration
Richard Gill	Independent board member	-	Current	15y 6m
{fdhe{a	Independent board member	-	Current	5y 1m
wmajutc	Independent board member	-	Current	7y 6m
tlzavvl	Independent board member	-	Current	8y 8m
rijnlpk	Independent board member	-	Current	8y 2m
jvlpoyg	Independent board member	-	Current	4y 8m
udxbtjj	Independent board member	-	Current	4y 6m
naavfwp	Independent board member	-	Current	9y 6m

View details of Cognoptix's Founder profiles and Board Members

Cognoptix's employee count trend

Cognoptix has 1 employees as of May 26. Here is Cognoptix's employee count trend over the years:

Uncover Cognoptix's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Cognoptix include Neuralight, neuroClues and Tobii Dynavox. Here is the list of Top 10 competitors of Cognoptix, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Neuralight 2021, San Francisco (United States), Series A	AI-based neurological evaluation and assessment tool for diagonosis	$30.5M	Koch Disruptive Technologies, Breyer Capital ... & 17 others	60/100
2nd	neuroClues 2020, Louvain-la-neuve (Belgium), Series A	Provider of eye-tracking devices for healthcare practitioners	$21.8M	Graph Ventures, Europa & 11 others	54/100
3rd	Tobii Dynavox 1983, Danderyd (Sweden), Public	Provider of assistive communication solution for differently abled people via eye-tracking	-	Vestar Capital Partners	53/100
4th	NovaSight 2016, Lod (Israel), Series B	Provider of eye-tracking-based solutions for vision assessment and treatment	$20M	Rimonci, EIT Health	51/100
5th	Neurotrack 2012, Redwood City (United States), Series C	Provider of clinical assessment tool to diagnose neurological disorders	$57.8M	Khosla Ventures, Sozo Ventures & 17 others	50/100
6th	Rebion 2009, Boston (United States), Seed	Provider vision scanning devices to diagnose brain diseases	$7.46M	NIH, Carnegie Mellon University & 2 others	50/100
7th	MJN Neuroserveis 2014, Blanes (Spain), Series A	Developer of a wearable device that evaluates the risk of epileptic seizures	$631K	Enisa, Ship2B & 4 others	49/100
8th	Winterlight Labs 2015, Toronto (Canada), Acquired	AI-powered speech analysis technology to detect cognitive impairments	$5.73M	Hikma Ventures, GSVP & 9 others	48/100
9th	EyeControl 2014, Tel Aviv (Israel), Series A	Eye controled communication device solution for ALS patients	$7.5M	Connecticut Innovations, Menomadin Foundation ... & 13 others	46/100
10th	C. Light Technologies 2014, Berkeley (United States), Seed	Developer of eye-tracking solution provider to detect and monitor neurodegenerative diseases	$3.25M	Creative Ventures, Alzheimer's Drug Discovery ... & 10 others	46/100
19th	Cognoptix 2001, Acton (United States), Series D	Developer of non-invasive eye scanning tests for early detection of Alzheimer's Disease	$41.3M	Quan Funds, Launchpad Venture Group & 12 others	39/100